Home/Laigo Bio/Matthew Baker
MB

Matthew Baker

CEO

Laigo Bio

Roles

Board MemberatFusion Antibodies

Therapeutic Areas

Laigo Bio Pipeline

DrugIndicationPhase
Oncology ProgramsNovel IO targets & intractable oncogenic driversPreclinical
Auto-immunity ProgramsAutoimmune disease & graft rejectionPreclinical